Agnos Therapeutics Inc.
Baltimore, MD
- UEI
- LVT2HHBULF54
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1205 N Gay St, Baltimore, MD 21213, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Human ipsc derived organoid therapeutics for the treatment of inherited blindness | National Eye Institute (NIH) | $397,163 |
Quick answers
Is Agnos Therapeutics Inc. registered in SAM.gov?
Yes. Agnos Therapeutics Inc.'s SAM.gov registration is active through January 8, 2027.
What is Agnos Therapeutics Inc.'s most recent federal award?
Agnos Therapeutics Inc.'s most recent federal grant award is Human ipsc derived organoid therapeutics for the treatment of inherited blindness (R41EY038591), from National Eye Institute (NIH), on August 1, 2026.
On GovTribe
See Agnos Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors